He didn’t blame our slow enrollment on funding. He without straight out saying that Gilead and Big pharma can pay for results and that we are able to still show stat sig data even with very small trial numbers which is remarkable. He also stated that big pharma can do 5,000 patients studies and show 5100 vs 4900 and state they had significant difference. It’s not all about funds our long trial study once it starts has a waiting list already from DR recknor should fill super fast. 5 sites have been selected in U.K yo start recruiting soon and they got approved for up to 10 sites in U.K so hopefully they will take advantage of them all. They need to get Leronlimab name known as much as possible if it means giving more leronlimab away for free at trials all over the world do it because one we get 1 approval the rest will flow in and the flood gates will open with revenues from Covid HIV 2021 and cancers soon after, Nash? and other blood brain barrier diseases Alzheimer’s etc....